Effects of RAS in Stroke
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShu-Mei Wang
About this trial
The goal of this study is to to examine whether rhythmic auditory stimulation improved movement speed, movement function of executing activities of daily living, and movement recovery of the affected upper limb, as well as quality of life in stroke patients. The main questions it aims to answer are:
* Does rhythmic auditory stimulation improve movement speed in stroke patients? * Does rhythmic auditory stimulation improve movement function of executing activities of daily living in stroke patients? * Does rhythmic auditory stimulation improve movement recovery of the affected upper limb in stroke patients? * Does rhythmic auditory stimulation improve quality of life in stroke patients?
Researchers will compare movement training with the aid of rhythmic auditory stimulation to movement training without the aid of rhythmic auditory stimulation to see if rhythmic auditory stimulation works to improve movement speed, movement function of executing activities of daily living, and movement recovery of the affected upper limb, as well as quality of life in stroke patients.
Participants will:
* Undergo movement tests and fill out questionnaires before and after the movement training program * Receive movement training for 40 minutes per session and three sessions per week for a total of 24 sessions
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
(1) Diagnosed with either ischaemic or hemorrhagic stroke, and a first-time occurrence;
(2) A unilateral stroke;
(3) The onset occurred six months or more prior to the experiment, indicating a chronic stage of stroke;
(4) The affected upper limb's proximal and distal joints are between Brunnstrom stages four to six, ensuring that the affected limb can execute the upper-limb functional movement training of this study;
Disqualifiers
(1) Neurological diseases or medical conditions that affect upper-limb movements or hearing;
(2) Being participating in other experimental studies related to drug treatment or upper-limb movement therapy.
Trial design
Design model
Parallel
Treatments tested in this trial
rhythmic auditory stimulation incorporated in upper-limb movement training
BehavioralRhythmic auditory stimulation will be metronome beat sound with different tempi and will be incorporated in upper-limb movement training, which will last for 40 minutes per session, three sessions per week, and a total of 24 sessions.
Upper-limb movement training
BehavioralUpper-limb movement training will last for 40 minutes per session, three sessions per week, and a total of 24 sessions.
Treatment groups
68 Participants
are divided into 2 treatment groupsGroup A: Experiment groupExperimental treatment 1 intervention
Group B: Control GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Nine-Hole Peg Test
A larger value (the recorded time for completing the task) means a slower movement.
Time frame
Up to 1 week right before the 1st session of the intervention2
Nine-Hole Peg Test
A larger value (the recorded time for completing the task) means a slower movement.
Time frame
Up to 1 week right after the last session of the intervention3
Box and Block Test
A larger value (the number of blocks) means a faster movement.
Time frame
Up to 1 week right before the 1st session of the intervention4
Box and Block Test
A larger value (the number of blocks) means a faster movement.
Time frame
Up to 1 week right after the last session of the interventionSecondary outcomes
1
Jebsen-Taylor Hand Function Test
A larger value (the time for completing the task) of each task means a slower movement.
Time frame
Up to 1 week right before the 1st session of the intervention2
Jebsen-Taylor Hand Function Test
A larger value (the time for completing the task) of each task means a slower movement.
Time frame
Up to 1 week right after the last session of the intervention3
the Fugl-Meyer Assessment
A higher value means better movement recovery.
Time frame
Up to 1 week right before the 1st session of the intervention4
the Fugl-Meyer Assessment
A higher value means better movement recovery.
Time frame
Up to 1 week right after the last session of the interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Shu-Mei Wang
Lead sponsor
National Taipei University of Nursing and Health Sciences
Sponsor institution
Source ClinicalTrials.gov